Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olmesartan vs Losartan in Mild to Moderate Essential Hypertension
NCT00857285Phase 3Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- May 2002
- Primary completion
- Aug 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of olmesartan in essential hypertension, sponsored by Daiichi Sankyo Co., Ltd.. Started May 2002; status: completed.
02
Drugs
olmesartan
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT00857285.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00857285.